| Jul 01, 2026 | Started Hematology/Oncology Fellowship at Stanford. |
| Jun 01, 2025 | New paper in Nature Genetics on tamoxifen-induced PI3K activation in early-stage uterine cancer (Kübler et al., 2025). |
| Feb 01, 2025 | Published a contemporary treatment review on AL amyloidosis for nephrologists in Nephrology Dialysis Transplantation (Anand et al., 2025). |
| Aug 01, 2024 | New paper in the American Journal of Hematology: machine-learning based subgroups of systemic AL amyloidosis and their association with mortality and end-stage kidney disease (Anand et al., 2024). |
| Jun 17, 2024 | Started Internal Medicine residency at Stanford, in the Translational Investigator Pathway. |
| Apr 01, 2024 | Received the Junior Investigator Travel Award from the International Society of Amyloidosis. |
| Jul 20, 2023 | Our CPTAC pan-cancer proteogenomics studies are out in Cell and Cancer Cell, including work on post-translational modifications (Geffen et al., 2023), oncogenic drivers (Li et al., 2023), and shared data resources (Li et al., 2023). |
| Sep 01, 2022 | New paper in Nature Communications: genetic subtypes of smoldering multiple myeloma are associated with distinct pathogenic phenotypes and clinical outcomes (Bustoros et al., 2022). |
| Jun 01, 2022 | Our cross-tissue single-nucleus atlas of the human body is published in Science as part of the GTEx Consortium (Eraslan et al., 2022). |